Amphetamine

30 October 2009

Products Affected - Description

Amphetamine mixed salts extended release capsules, Teva
5 mg capsules, 100 count (NDC 00555-0790-02)
10 mg capsules, 100 count (NDC 00555-0787-02)
15 mg capsules, 100 count (NDC 00555-0791-02)
20 mg capsules, 100 count (NDC 00555-0788-02)
25 mg capsules, 100 count (NDC 00555-0792-02)
30 mg capsules, 100 count (NDC 00555-0789-02)

Reason for the Shortage

Teva has their product on back order due to problems obtaining raw materials.

Estimated Resupply Dates

• Teva has all of their amphetamine mixed salt extended-release capsules on back order with no release date.
• Shire has available their Adderall XR capsules in 5 mg (NDC 54092-0381-01), 10mg (NDC 54092-0383-01), 15 mg (NDC 54092-0385-01), 20 mg (NDC 54092-0387-01), 25 mg (NDC 54092-0389-01) and 30 mg (NDC 54092-0391-01) 100 count bottles.
• Global Pharmaceuticals has available their amphetamine mixed salt extended-release capsules in 5 mg (NDC 00115-1328-01), 10 mg (NDC 00115-1329-01), 15 mg (NDC 00115-1330-01), 20 mg (NDC 00115-1331-01), 25 mg (NDC 00115-1332-01), and 30 mg (NDC 00115-1333-01) 100 count bottles.
  

Related Shortages

• Caffeine/Caffeine and Sodium Benzoate Injection— Resolved

Updated

October 30, 2009, University of Utah, Drug Information Service. Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.

Back to Drug Shortage Product Bulletins